Dr. Michel Baudry
September 5, 2019
Southborough startup lands $3.8M DoD grant for brain injury drug
The scientific founder of a Southborough startup pharmaceutical company has landed a $3.8 million grant from the U.S. Department of Defense to help develop a drug to treat traumatic brain injury and concussions.
Dr. Michel Baudry, co-founder and chief scientific officer of NeurAegis, will use the funds from the department’s Combat Casualty Care Research Program to develop a neuroprotective drug candidate in preparation for in-human trials.
In a statement, Baudry, the principal investigator for the project, said the company has identified a molecular mechanism that shows efficacy against cell death and damage following brain injury.
The company is partnering with Pomona, Calif.,-based Western University of Health Sciences where Baudry runs a lab. The company has an exclusive worldwide license to commercialize the technology from Baudry’s lab.
The company is also developing treatments for other neurological disorders, including epilepsy, mild cognitive impairment and acute glaucoma.
WBJ Web Partners
Most Recent
Most Recent
0 Comments